Introduction SARS-CoV-2 is a novel virus that causes coronavirus disease-19 (COVID-19).
Antiviral and immunomodulatory agents have been proposed as potential treatments …

Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-
2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute …

In the last decade Open Science principles have been successfully advocated for and are
being slowly adopted in different research communities. In response to the COVID-19 …

Background In our institute in Marseille, France, we initiated early and massive screening for
coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with …

The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness,
hospitalizations, and death. The complex and multifaceted pathophysiology of life …

The aim of this study was to describe the outcomes of patients with coronavirus disease
2019 (COVID-19) in the outpatient setting after early treatment with zinc, low-dose …

Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …

Background For the past few months, HMOs have faced crowded emergency rooms and
insufficient hospital and intensive-care-unit beds, all from the worst pandemic of this century …

Background Hydroxychloroquine has not been associated with improved survival among
hospitalized COVID-19 patients in the majority of observational studies and similarly was not …

Introduction Over the last few months, coronavirus disease 2019 (COVID-19) pandemic
caused by the novel coronavirus SARS-CoV-2 has posed a serious threat to public health …